Overview
Background
I am the lead of the Effective and Efficient Healthcare program at the Centre for the Business and Economics of Health at The University of Queensland. I also lead Health Technology Assessment for the Centre, which involves evaluating submissions made to the Australian Government to reimburse new medicines and medical devices through the Pharmaceutical benefits Scheme (PBS) and the Medicare Benefits Schedule (MBS). My research is focused on the economic evaluation of health interventions to inform decision making and promote value-based health care. I have pioneered the application of Value of Information (Research) analysis to enhance the efficiency of clinical trials and maximise the return on investment from medical research.
I have extensive experience working with key stakeholders including consumers, clinicians, decision makers and researchers. I am chief investigator on over $45 million Category 1 grants from the NHMRC, MRFF and ARC. In addition, I lead several projects for the Department of Health and other peak organisations.
I chair the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)-Oncology GroupI, and I am the past chair of the Clinical Oncology Society of Australia's (COSA)-Epidemiology Group and the Australian Clinical Trials Alliance (ACTA)-Research Prioritisation Group. I am an Associate Editor for Value in Health, and an Editorial Board Member for Medical Decision Making and PharmacoEconomics-open journals.
Availability
- Professor Haitham Tuffaha is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Doctor of Philosophy, Griffith University
Research interests
-
Economic Evaluation of Healthcare Interventions
-
Health Technology Assessment
-
Value-Based Health Care
-
Cancer Economics
-
Medications use and safety
Research impacts
My research has significantly influenced health policy in Australia and internationally and was pivotal in the allocation of almost $1 billion in new drugs and medical technologies in Australia over the past ten years. My research program about evaluating new health technologies using Value of Information/implementation analyses led to a paradigm shift in the economic evaluation of new interventions and improved patient access to health innovations (e.g., genetic testing, targeted therapies). My research shifted the way clinical trials are prioritised and funded towards a value-based approach, which informed the development of the Australian Clinical Trials Alliance Research Prioritisation Framework.
I have published over 100 peer reviewed articles and technical reports for leading organisations, including 45 technical reports for the Australian Government on the economic evaluation of novel drugs, devices and services for a range of conditions including cancer, genetic testing, cardiovascular disease and liver disease.
Works
Search Professor Haitham Tuffaha’s works on UQ eSpace
2018
Journal Article
Dressings and securements for the prevention of peripheral intravenous catheter failure in adults (SAVE): a pragmatic, randomised controlled, superiority trial
Rickard, Claire M., Marsh, Nicole, Webster, Joan, Runnegar, Naomi, Larsen, Emily, McGrail, Matthew R., Fullerton, Fiona, Bettington, Emilie, Whitty, Jennifer A., Abu Choudhury, Md, Tuffaha, Haitham, Corley, Amanda, McMillan, David J., Fraser, John F., Marshall, Andrea P. and Playford, E. Geoffrey (2018). Dressings and securements for the prevention of peripheral intravenous catheter failure in adults (SAVE): a pragmatic, randomised controlled, superiority trial. Lancet, 392 (10145), 419-430. doi: 10.1016/S0140-6736(18)31380-1
2018
Journal Article
Medication adherence in older patients with dementia: a systematic literature review
El-Saifi, Najwan, Moyle, Wendy, Jones, Cindy and Tuffaha, Haitham (2018). Medication adherence in older patients with dementia: a systematic literature review. Journal of Pharmacy Practice, 31 (3), 322-334. doi: 10.1177/0897190017710524
2018
Journal Article
The Australian managed entry scheme: are we getting it right?
Tuffaha, Haitham W. and Scuffham, Paul A. (2018). The Australian managed entry scheme: are we getting it right?. Pharmacoeconomics, 36 (5), 555-565. doi: 10.1007/s40273-018-0633-6
2018
Journal Article
Estimating the healthcare costs of treating prostate cancer in Australia: A Markov modelling analysis
Gordon, Louisa G., Tuffaha, Haitham W., James, Robbie, Keller, Andrew T., Lowe, Anthony, Scuffham, Paul A. and Gardiner, Robert A. (2018). Estimating the healthcare costs of treating prostate cancer in Australia: A Markov modelling analysis. Urologic Oncology, 36 (3) 91.e7, e7-e15. doi: 10.1016/j.urolonc.2017.10.024
2018
Journal Article
Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers
Tuffaha, Haitham W., Mitchell, Andrew, Ward, Robyn L., Connelly, Luke, Butler, James R. G., Norris, Sarah and Scuffham, Paul A. (2018). Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers. Genetics in Medicine : Official Journal of the American College of Medical Genetics, 20 (9), 985-994. doi: 10.1038/gim.2017.231
2018
Conference Publication
Can technology improve medication adherence in older people with dementia?
El-Saifi, Najwan, Moyle, Wendy, Jones, Cindy and Tuffaha, Haitham (2018). Can technology improve medication adherence in older people with dementia?. 16th International Conference, ICOST 2018, Singapore, 10-12 July, 2018. Cham, Switzerland: Springer. doi: 10.1007/978-3-319-94523-1_1
2018
Conference Publication
Value For Money, the Overlooked Aspect in Research Funding Decisions
Tuffaha, H., El-Saifi, N. and Scuffham, P. (2018). Value For Money, the Overlooked Aspect in Research Funding Decisions. Moving Into Action: Informing Policy and Strengthening Healthcare Systems in Asia-Pacific, Tokyo, Japan, 8-11 September 2018. Elsevier. doi: 10.1016/j.jval.2018.07.413
2018
Conference Publication
Rare Cancers, no Rare Solutions: Risk Sharing Arrangemnts to Reimburse Medicines for Rare Cancers in Australia
Tuffaha, H. and Scuffham, P. (2018). Rare Cancers, no Rare Solutions: Risk Sharing Arrangemnts to Reimburse Medicines for Rare Cancers in Australia. Moving Into Action: Informing Policy and Strengthening Healthcare Systems in Asia-Pacific, Tokyo, Japan, 8-11 September 2018. Elsevier. doi: 10.1016/j.jval.2018.07.839
2018
Conference Publication
Can we prospectively assess the value for money of oncology clinical trials?
Tuffaha, Haitham, Chambers, Suzanne and Scuffham, Paul (2018). Can we prospectively assess the value for money of oncology clinical trials?. COSA's 45th Annual Scientific Meeting, Mesothelioma and Gastro‐Intestinal Cancers: Technology and Genomics, Perth, WA Australia, 13–15 November 2018. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.13089
2017
Conference Publication
INTERNATIONAL HTA EXPERIENCE WITH TARGETED THERAPY APPROVALS FOR LUNG CANCER
Maraiki, R., Bymes, J., Tuffaha, H. and Hider, M. (2017). INTERNATIONAL HTA EXPERIENCE WITH TARGETED THERAPY APPROVALS FOR LUNG CANCER. NEW YORK: ELSEVIER SCIENCE INC.
2017
Journal Article
A program to increase research productivity among hospital pharmacists
Nazer, Lama H., Tuffaha, Haitham and Jaddoua, Saad (2017). A program to increase research productivity among hospital pharmacists. Journal of Pharmacy Practice, 30 (3), 336-341. doi: 10.1177/0897190016645432
2017
Journal Article
Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia
Gordon, Louisa G., James, Robbie, Tuffaha, Haitham W., Lowe, Anthony and Yaxley, John (2017). Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia. Journal of Magnetic Resonance Imaging, 45 (5), 1304-1315. doi: 10.1002/jmri.25504
2017
Journal Article
Health care and pharmacy practice in Jordan
Nazer, Lama H. and Tuffaha, Haitham (2017). Health care and pharmacy practice in Jordan. Canadian Journal of Hospital Pharmacy, 70 (2), 150-155. doi: 10.4212/cjhp.v70i2.1649
2017
Journal Article
Setting medical research future fund priorities: assessing the value of research
Tuffaha, Haitham W., Andronis, Lazaros and Scuffham, Paul A. (2017). Setting medical research future fund priorities: assessing the value of research. Medical Journal of Australia, 206 (2), 64-65.e1. doi: 10.5694/mja16.00672
2017
Conference Publication
International HTA experience with targeted therapy approvals For lung cancer
Maraiki, F., Byrnes, J., Tuffaha, H. and Hider, M. (2017). International HTA experience with targeted therapy approvals For lung cancer. ISPOR 20th Annual European Congress, Glasgow, United Kingdom, 4-8 November 2017. New York, NY USA: Elsevier. doi: 10.1016/j.jval.2017.08.335
2017
Conference Publication
Improving patient access to novel cancer drugs in Australia: are we there yet?
Tuffaha, Haitham and Scuffham, Paul (2017). Improving patient access to novel cancer drugs in Australia: are we there yet?. COSA's 44th Annual Scientific Meeting, Immunotherapy: Molecules and Mountains, Sydney, NSW Australia, 13-15 November 2017. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.
2016
Journal Article
How often should general practitioners provide nutrition care to patients? A forecasting activity to determine the target frequency for chronic-disease management in Australia
Ball, Lauren, Lee, Patricia, Ambrosini, Gina L., Hamilton, Kyra and Tuffaha, Haitham (2016). How often should general practitioners provide nutrition care to patients? A forecasting activity to determine the target frequency for chronic-disease management in Australia. Australian Journal of Primary Health, 22 (5), 383-387. doi: 10.1071/py16060
2016
Journal Article
Value of information analysis informing adoption and research decisions in a portfolio of health care interventions
Tuffaha, Haitham W., Gordon, Louisa G. and Scuffham, Paul A. (2016). Value of information analysis informing adoption and research decisions in a portfolio of health care interventions. MDM Policy & Practice, 1 (1), 238146831664223. doi: 10.1177/2381468316642238
2016
Journal Article
Cost-effectiveness analysis of nutritional support for the prevention of pressure ulcers in high-risk hospitalized patients
Tuffaha, Haitham W., Roberts, Shelley, Chaboyer, Wendy, Gordon, Louisa G. and Scuffham, Paul A. (2016). Cost-effectiveness analysis of nutritional support for the prevention of pressure ulcers in high-risk hospitalized patients. Advances in Skin and Wound Care, 29 (6), 261-267. doi: 10.1097/01.ASW.0000482992.87682.4c
2016
Journal Article
Efficient value of information calculation using a nonparametric regression approach: an applied perspective
Tuffaha, Haitham W., Strong, Mark, Gordon, Louisa G. and Scuffham, Paul A. (2016). Efficient value of information calculation using a nonparametric regression approach: an applied perspective. Value in Health, 19 (4), 505-509. doi: 10.1016/j.jval.2016.01.011
Funding
Current funding
Supervision
Availability
- Professor Haitham Tuffaha is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Evaluation of Indonesian Chronic Diseases Management Program: Patients participation, adherence to the treatment and cost-effectiveness of the program
Principal Advisor
Other advisors: Associate Professor Adam La Caze, Dr Kim Edmunds
Completed supervision
-
2024
Doctor Philosophy
Assessing the Value for Money of Integrating Exercise as Therapy after Gynaecological Cancer Treatment
Principal Advisor
Other advisors: Professor Sandie McCarthy
Media
Enquiries
Contact Professor Haitham Tuffaha directly for media enquiries about:
- Cancer Economics
- Health Economics
- Health Services Research
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: